You seem to have paid little attention to your long term holding. Most of the dividend was spun off to ABBV. If you are still holding that, along with ABT, your total dividend has actually increased. In answer to your question, there are no rosy price projections for ABT. It is going to have to prove it can succeed without prescription pharmaceuticals as part of its product line. It's not even clear at this point just what sector it will be assigned to, since most of the medical products companies are comparatively small. Just as a free word of advice, you really should be getting your investment information somewhere other than from the Yahoo boards. Not every poster has your best interests at heart. Good luck.